Charles River Laboratories International Inc at Barclays Global Healthcare Conference (Virtual) Transcript
All right. There we go. And we're live. Hi everybody, Luke Sergott from Barclays. I cover Life Science Diagnostics & Tools here. It's my pleasure to have Jim Foster from Charles River Labs. About a seasoned veteran in the space as they come, and a transparent and clear message can be provided. So if you want to take over and provide a couple of sentences or introduction, then I'll just dive into questions.
Great. Thanks, Luke. Nice to be here. Just by way of quick background. We ended fiscal '20 very strong with 7% growth rate in a COVID world, which we were extremely pleased with. We did -- we acquired 2 cell product companies with cellular therapy, research and development during the year. We ended the year with the acquisition of a large molecule discovery platform, which was one of our technology deals that we just announced a couple of weeks ago now, I think, that we signed, but
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
